唐人神(002567.SZ):公司有“新美系”和“新丹系”兩種種豬體系
格隆匯7月18日丨唐人神(002567.SZ)近期在接待機構投資者調研時表示,公司有“新美系”和“新丹系”兩種種豬體系。目前“新美系”種豬佔多數,它具有體型好、生長速度快、瘦肉率高等特點。此外,公司2020年引進1400多頭曾祖代新丹系種豬,經過2年多時間的培育,丹系種豬體系初具規模,未來公司種豬體系將逐步由“新美系”向高繁殖性能的“新丹系”種豬體系過渡,PSY預計可達到28頭以上,若全部完成種豬培育後,預計可滿足未來1000萬頭商品豬年出欄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.